Aptose Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch APTO and buy or sell other stocks, ETFs, and their options commission-free!

About APTO

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. 

CEO
William G. Rice, PhD
CEOWilliam G. Rice, PhD
Employees
13
Employees13
Headquarters
Toronto, Ontario
HeadquartersToronto, Ontario
Founded
1986
Founded1986
Employees
13
Employees13

APTO Key Statistics

Market cap
5.56M
Market cap5.56M
Price-Earnings ratio
-0.06
Price-Earnings ratio-0.06
Dividend yield
Dividend yield
Average volume
1.75K
Average volume1.75K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$32.40
52 Week high$32.40
52 Week low
$1.10
52 Week low$1.10

People also own

Based on the portfolios of people who own APTO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.